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Abstract
Consumption of fruit and vegetable is a key component of a healthy and sustainable diet. However, their accurate
dietary assessment remains a challenge. Due to errors in self-reporting methods, the available dietary information is
usually biased. Biomarkers of intake constitute objective tools to better reflect the usual or recent consumption of
different foods, including fruits and vegetables. Partners of The Food Biomarker Alliance (FoodBall) Project have
undertaken the task of reviewing the available literature on putative biomarkers of tropical fruit intake. The identified
candidate biomarkers were subject to validation evaluation using eight biological and chemical criteria. This
publication presents the current knowledge on intake biomarkers for 17 tropical fruits including banana, mango, and
avocado as the most widely consumed ones. Candidate biomarkers were found only for banana, avocado, and
watermelon. An array of banana-derived metabolites has been reported in human biofluids, among which 5-
hydroxyindole-acetic acid, dopamine sulfate, methoxyeugenol glucuronide, salsolinol sulfate, 6-hydroxy-1-methyl-1,2,3,
4-tetrahydro-β-carboline-sulfate, and other catecholamine metabolites. Their validation is still at an early stage, with
insufficient data on dose-response relationship. Perseitol and mannoheptulose have recently been reported as
candidate biomarkers for avocado intake, while the amino acid citrulline has been associated with watermelon intake.
Additionally, the examination of food composition data revealed some highly specific phytochemicals, which
metabolites after absorption may be further studied as putative BFI for one or several tropical fruits. To make the field
move forward, untargeted metabolomics, as a data-driven explorative approach, will have to be applied in both
intervention and observational studies to discover putative BFIs, while their full validation and the establishment of
dose-response calibration curves will require quantification methods at a later stage.
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Background
More than 800 tropical fruits have been described, but
only a small number are widely consumed [1]. Geo-
graphically, tropical fruits have their origin in the tropics
of Cancer and Capricorn in the north and south of the
equator covering most of the tropical and subtropical
areas of Asia, Africa, Central America, South America,
the Caribbean, and Oceania. In comparison to the tem-
perate fruits such as apple, pears, and berries, tropical
fruits are gaining terrain in global production and trade
due to a growing demand from consumers. As an ex-
ample, the production of avocados in the top producing
country, Mexico, rose 1900% between 1961 and 2017
[2]. Moreover, mango availability was reported to in-
crease from 1 kg per capita in 2007 to 1.8 kg per capita
in 2017 in the USA, and from 0.4 kg to 0.7 kg in the
European Union [3].
Several tropical fruits have been studied for their effect
in human health due to their content in specific bioactive
compounds. Of these, pomegranate has received much at-
tention in recent years. A recent meta-analysis of 8 ran-
domized controlled trials (RCT) (n = 574) showed that the
intake of pomegranate juice reduces systolic (− 4.96, 95%
CI − 7.67 to − 2.25mmHg, P < 0.001) and diastolic blood
pressure (− 2.01, 95% CI − 3.71 to− 0.31, P = 0.021) [4].
The effects of pomegranate on human health, including
LDL-cholesterol, triglycerides, and glucose reduction, have
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been ascribed to its content in ellagitannins and to uro-
lithins, their gut microbiota metabolites [5, 6].
Unlike pomegranate, information regarding the health
effects of other tropical fruits, including the widely con-
sumed banana, is remarkably scarce. To tackle this, well-
conducted human studies with randomized controlled
designs and prospective cohort studies with accurate
dietary assessment will be needed.
Food Frequency questionnaires (FFQs) are widely used
to assess fruit intake, but they have several disadvan-
tages. It has been shown that the intake of fruits and
vegetables (F&V) is often over-reported when assessed
by food frequency questionnaires, due to social desirabil-
ity bias [7]. Moreover, dietary questionnaires rarely
evaluate the fruit consumption down to specific foods
and varieties, and even in detailed FFQs, not much at-
tention is given to tropical fruits, because of their diver-
sity and low average intake in most studied populations
compared to other fruits. In Western countries, except
for banana and avocado, tropical fruits are often not
considered in the FFQs or they are integrated in a more
or less heterogeneous food group. For example, water-
melon and melon are constantly listed together [8, 9]
hindering the assessment of their respective intakes. In
some producing countries such as Singapore, Mexico,
and Brazil, FFQs consider tropical fruits including guava,
kiwi, papaya, dragonfruit, watermelon, dates, and per-
simmon [10–12], although in an inconsistent manner.
One could argue that the well-designed dietary instru-
ments may suffice to obtain accurate intake information
of tropical fruits. However, self-reporting methods will
always be subject to imprecision associated to recall
errors, difficulty to assess portion size, and social desir-
ability bias. Furthermore, listing all tropical fruit indi-
vidually would significantly expand the questionnaires
and increase participant burden. The use of dietary bio-
markers, whose associated errors are independent from
that of questionnaire instruments, has the potential to
assist in accurately determining dietary intake, and
hence better unravel the associations between diet and
human health.
BFIs originate from compounds that are specific for a
given food or food group, and become bioavailable after
their consumption [13]. Plasma vitamin C and caroten-
oids increase after tropical fruit intake and are bio-
markers commonly used to assess the total intake of
F&V [14]. However, their use is not without limitations.
The bioavailability of carotenoids fluctuates according to
the alongside diet or food preparation, e.g., simultaneous
intake of fat enhances their absorption [15, 16]. Further-
more, plasma vitamin C concentration exhibits satur-
ation kinetics, meaning that its collinearity with dietary
intake stops at a certain point, especially in well-
nourished subjects where baseline concentrations are
observed at ~ 60 μmol/L [17]. Plasma vitamin C is fur-
ther challenged by several external factors including pre-
analytical conditions such as sample handling,
temperature, and conditions of storage [18].
The Food Biomarkers Alliance (FoodBAll JPI-project;
www.foodmetabolome.org), in an effort to collate the
most comprehensive panel of BFIs as possible for over
140 commonly consumed foods, has conducted a series
of reviews of the literature according to the guidelines
established by the consortium [19]. The obtained BFIs
are evaluated according to eight defined criteria to qual-
ify their applicability as BFIs in further nutritional and
health-related research [20]. The vision is to develop
analytical methods that could quantify in a cost-effective
way a battery of dietary biomarkers to validate or com-
plement dietary questionnaires. Within the FoodBall ini-
tiative, the objectives of the present work are as follows:
(1) retrieve from an extensive literature search the com-
pounds currently used as BFIs for tropical fruits and
those which are specific enough to represent putative
BFIs and (2) outline the available knowledge and provide
the current level of validation of the collated candidate
BFIs for tropical fruits.
Methods
Selection of food groups
For the present review, 16 tropical fruits including the
most consumed in the world according to FAO produc-
tion and trading data were selected [3]. This review as-
sesses the following fruits: dessert banana (Musa
acuminata), mango (Mangifera indica), pineapple (Ana-
nas comosus), papaya (Carica papaya), avocado (Persea
Americana), pomegranate (Punica granatum), kiwifruit
(Actinidia), lychee (Litchi chinensis), persimmon (Dia-
sporos kaki), guava (Psidium guava), passion fruit (Passi-
flora edulis), acerola (Malpighia emarginata), dragon
fruit (Hylocereus undatus), coconut (Cocos nucifera),
watermelon (Citrullus vulgaris), muskmelon (Cucumis
melo), and date (Phoenix dactylifera).
Search for relevant BFIs research papers
An extensive literature search was carried out to collect
all available information on the already used or new pu-
tative BFIs for the selected fruits. The BFIRev protocol
(Food Intake Biomarker Reviews) elaborated with the
guidance of the PRISMA statement (Preferred Reporting
Items for Systematic reviews and Meta-Analyses) and
described in Pratico et. al. [19] was followed. Briefly, a
primary search was performed in the three literature
search databases, Scopus, PubMed central, and Web of
Science, with the name of the specific fruit and its bo-
tanical genus, i.e., (Banana OR Musa*) OR (Mango OR
Mangifera* OR Pineapple OR Ananas* OR Papaya OR
Carica* OR Avocado OR Persea* OR Pomegranate OR
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Punica* OR Kiwi* OR Actinidia* OR Lychee OR Lichee
OR Litchi* OR Persimmon OR Diospyros* OR Guava
OR Psidium* OR Passion fruit OR Passiflora* OR Acer-
ola OR Malpighia* OR Pitaya OR Pitahaya OR Dragon
fruit OR Hylocereus* OR Coconut OR Cocus* OR
Watermelon OR Citrullus* OR Muskmelon OR Melon
OR Cantaloupe OR Cucumis* OR Phœnix dactylifera)
along with the common keywords: AND (urine OR
plasma OR serum OR excretion OR blood) AND (Hu-
man* OR men OR women OR patient* OR volunteer*
OR participant*) AND (Biomarker* OR marker* OR me-
tabolite* OR Biokinetics OR Biotransformation OR
Pharmacokinetics OR bioavailability OR ADME) AND
(Intake OR meal OR diet OR ingestion OR administra-
tion OR consumption OR eating OR drink*). Keywords
were used in the fields [Topic], [All fields], and [Article
Title/Abstract/Keywords] for Web of Science, PubMed,
and Scopus, respectively. All searches were carried out in
March 2016 and updated in January 2019. A last search in
April 2020 resulted in no new putative biomarkers. Only
papers in the English language were considered eligible,
and no restriction on the date of publication was applied.
Articles showing results of human intervention studies
(randomized controlled trials, single-dose, short-term or
long-term studies) or observational studies (cohort, case-
control, cross-sectional studies) were considered eligible.
After removal of duplicates, a first selection of papers was
performed according to the relevance of the abstract and
title. Full texts were obtained for the selected articles and
further assessed for eligibility according to their relevance
for the identification of BFIs for all tropical fruits. Some of
the publications found in the reference list of the selected
articles were also included at this stage. Furthermore, for
those tropical fruits for which no information in human
studies was available, we carried out an additional search
in food composition databases including, Dictionary of
Food Compounds, FooDB and KNApSAck [21–23], and
used the text-mining tools, Polysearch2 [24] and Core-
mine [25] medical online database, to identify specific
compounds for each fruit that may be further investigated
as putative BFIs [26].
Characterization of candidate BFIs
For each putative biomarker identified, a secondary
search allowed to retrieve relevant information to assess
its specificity, pharmacokinetics, dose-response relation-
ship, robustness, and reliability, as well as the quality of
its method(s) of analysis, in order to qualify its use as
BFI according to the validating scheme established by
Dragsted et al. [20].
The name of the putative biomarkers and their syno-
nyms were queried in the literature search databases along
with AND (biomarker* OR marker* OR metabolite* OR
biokinetics OR biotransformation OR pharmacokinetics
OR bioavailability OR ADME). Additionally, the com-
pounds were searched manually in the online databases
HMDB [27], FooDB [22], Phenol-Explorer [28], Dictionary
of Food Compounds [21], Duke’s phytochemical and
ethnobotanical databases [29], eBASIS [30], KNApSack
[23], and PhytoHub [31] to determine all the possible diet-
ary or metabolic origins of the candidate BFIs.
The list of candidate BFIs was reviewed and agreed
upon all authors.
Application of validation criteria
According to the method of Dragsted et al. [20], a valid-
ation assessment procedure was applied on the candidate
BFIs to assess their current status of validation and identify
the missing information for full validation. The validation
scheme is based on eight questions that encompass bio-
logical and chemical aspects: plausibility, dose-response,
time-response, robustness, reliability, stability, analytical
performance, and reproducibility (Table S1).
Results and discussion
A flowchart indicating the literature search and the re-
view process is shown in Fig. 1. After removal of dupli-
cates, the literature search yielded 1235 publications for
the tropical fruits. Of these, 40 articles reported relevant
information on putative biomarkers of intake. Five add-
itional articles were selected from the reference list of
the assessed publications or from the secondary search.
A summary of the retained literature and the list of the
specific candidate BFIs for tropical fruits are presented
in Table 1 and Fig. 2. The level of validation of the can-
didate BFIs is shown in Table 2. For an exhaustive pres-
entation of the results, a full list of all retained and non-
retained compounds is given in Table S2, with the main
reasons for inclusion or exclusion and the corresponding
references.
Banana biomarkers
Banana, which is the second most-produced fruit in the
world with 113 million tons and is among the three
most consumed fruits in Europe [56, 57], certainly de-
serves specific attention for identifying an intake bio-
marker. The metabolite 5-hydroxyindole acetic acid
(HIAA) was among the most studied compounds in as-
sociation with banana intake. Of the 23 publications
reviewed for this section, 10 reported the impact of
banana intake on HIAA in urine (Table 1). HIAA origi-
nates from the catabolism of serotonin by the
monoamine-oxidase (MAO, EC 1.4.3.4) and aldehyde
dehydrogenase (ALDH, EC 1.2.1.3) enzymes. Besides its
endogenous origin, serotonin can be provided in sub-
stantial amounts by several foods. Banana has a high
serotonin content (15 ± 2.4 μg/g FW) along with nuts
(87–398 μg/g), pineapple (17 ± 5.1 μg/g FW), plantain
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(30 ± 7.5 μg/g FW), kiwi fruit (5.8 ± 0.9 μg/g FW), plums
(4.7 ± 0.8 μg/g FW), and tomato (3.2 ± 0.6 μg/g FW)
[32]. The urinary excretion of HIAA increased by ~ 2–
26-fold after banana intakes ranging from 50 to 1000 g
[32–40, 49], and was comparable to that induced by an
oral dose of 10 mg of serotonin [33]. Along with its sul-
fated conjugate, HIAA was identified as a highly discrim-
inant compound (VIP > 2; R2 = 0.89, Q2 = 0.732) in a
randomized, controlled crossover meal study using
untargeted metabolomics to discover BFIs for banana
[49]. The important contribution of banana intake to
HIAA excretion level was also fortuitously observed
in a large study aiming at diagnosing neuroblastoma
in Japanese 18-month children. Neuroblastoma is a
catecholamine-producing tumor, and an elevated ex-
cretion of the dopamine metabolite homovanillic acid
was used as a diagnosis biomarker. Among the 103
cases identified with elevated homovanillic acid, 50
were false-positive cases caused by regular intake of
banana as weaning food, which was associated with
elevated excretion levels of both homovanillic acid
and HIAA [37].
While serotonin is not specific to banana, its con-
sumption produces a higher elevation of HIAA in urine
compared to other serotonin-rich foods, including to-
mato, pineapple, and kiwi [38, 39]. However, nuts intake
constitutes a probable confounder for the use of HIAA
as BFI for banana. Feldman et al. reported a higher ex-
cretion of HIAA after the ingestion of 100 g of walnuts
(7–59 mg/24 h) compared to 100 g of banana (4.8–15
mg/24 h) [32]. Recent studies using untargeted metabo-
lomics proposed HIAA in combination with other me-
tabolites as a candidate biomarker for nuts [58, 59].
Another potential confounder could be fresh tomato,
due to its high level of consumption in many popula-
tions, but not its processed forms (juices, canned tomato
or ketchup) as their serotonin content is much lower (<
0.2 μg/g FW) than in fresh tomato (6.4 μg/g FW) [60].
The robustness of urinary HIAA is thus not fully estab-
lished. It was not among the metabolites discriminating
low and high consumers of banana from non-consumers
in a cross-sectional study with 78 subjects [49]. More
studies with non-controlled dietary background and
examination of the confounding effect of nuts and
Fig. 1 Flow diagram of study selection according to the BFIRev procedure
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tomato are needed. While no data are available regard-
ing dose-response, the time-response is well documented
for HIAA, with a urinary excretion that peaks 2–4 h
after banana intake and returns to baseline levels 8–12 h
after consumption [33, 35, 36, 38, 49].
In addition to urine, plasma and serum concentrations
of HIAA also increase after banana intake, as reported in
four studies [41, 42, 47, 48]. Tohmola et al. measured
serum HIAA in response to 35 different foods and
showed that walnuts (102 g) produced the highest
Fig. 2 Overview of the literature evaluation process of the candidate biomarkers for banana and avocado, and the candidate biomarker
for watermelon
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elevation of HIAA (1.8 μmol/L), followed by banana (~
0.6 μmol/L for 300 g ingested), pineapple (0.46 μmol/L
for 330 g) and tomato (0.39 μmol/L for 362 g) [41].
Plasma concentrations of HIAA peaked 2 h after the in-
take of all foods and returned to baseline levels 6 h after
the intake of tomato and pineapple and 24 h after the in-
gestion of banana and walnuts. The calculated half-life
of HIAA in the circulation was of 1.3 h [41].
Wang et al. conducted a cross-sectional analysis that
correlated consumption, using FFQs, of 91 food items or
food groups to the non-fasting serum metabolome of
1369 post-menopausal women (Table 1). Herein, HIAA
was significantly correlated to banana consumption
(|r| = 0.21, P < 0.0001), although dopamine metabolites
showed a better ability to predict banana intake in the
same study [48].
Regarding the analytical aspects of the validation
scheme for BFIs, quantification of HIAA by HPLC-MS
in urine and serum samples is well established [61, 62].
Acidification of urine to a pH between 2 and 5 is recom-
mended for HIAA conservation [63, 64]. At pH 4, HIAA
was shown to be stable in urine for up to 30months at
− 20 °C, for 3 months at 4 °C, and for 3 weeks at room
temperature [63]. The validation criteria fulfilled so far
for HIAA as a biomarker of banana intake are presented
in Table 2.
Besides HIAA, the response of dopamine metabolites
to banana intake has been widely studied, mostly in
plasma and serum [42–44, 46–48], with one publication
on urine [49] (Table 1). Banana has a high dopamine
content (73 ± 24 μg/g) [38] compared to other dietary
sources such as avocado (4 μg/g), orange, cocoa powder,
and tomato (< 1 μg/g) [65]. In humans, dopamine is de-
graded into different metabolites by several pathways
[66]. Dopamine-sulfate is the main circulating form ori-
ginating from both dietary and endogenous dopamine
[67, 68]. 3-Methoxytyramine results from the metabol-
ism of dopamine through its methylation by the enzyme
catechol-O-methyl transferase (EC 2.1.1.6) [66]; 3-
methoxytyramine is further conjugated to its sulfate by
the enterocytes or the liver [69].
Dopamine derivatives have been reported as highly
distinctive metabolites for banana intake on various oc-
casions. In three intervention studies, banana intake was
studied for its effect on the physical endurance of male
cyclists, and an untargeted metabolomic analysis of
Table 2 Overview of the validation criteria for candidate intake biomarkers for banana and tropical fruitsa
Food item Metabolites Biofluid Q1 Q2 Q3a Q3b Q4 Q5 Q6 Q7 Q8
Banana 5-Hydroxyindole acetic acid Plasma Y U Y U U U Y Y U
Banana 5-Hydroxyindole acetic acid Urine Y U Y U U U Y Y U
Banana 3-Methoxytyramine sulfate Plasma Y U U U Y U U U U
Banana Dopamine sulfate Plasma Y U Y U Y U Y Y U
Banana Dopamine sulfate Urine Y Y* Y U U U Y Y U
Banana Methoxyeugenol glucuronide Urine Y Y* Y U U U U U U
Banana Salsolinol sulfate Urine Y Y* Y U U U U Y U
Banana 6-OH-MTβC sulfate Urine Y Y* U U U U U U U
Banana Methoxyeugenol glucuronide + Dopamine sulfate Urine Y Y* Y U Y Y U U U
Banana Methoxyeugenol-glucuronide + Dopamine sulfate + Salsolinol sulfate Urine Y Y* Y U Y Y U U U
Banana Methoxyeugenol glucuronide + Dopamine sulfate + 6-OH-MTβC sulfate + 2-
isopropylmalic acid
Urine Y Y* Y U Y Y U U U
Banana Methoxyeugenol glucuronide + Dopamine sulfate + Salsolinol sulfate +
Xanthurenic acid + 6-OH-MTβC sulfate
Urine Y Y* Y U Y Y U U U
Avocado Perseitol Urine Y U Y* U U U U U U
Avocado Mannoheptulose Urine Y U Y* U U U U U U
Watermelon Citrulline Plasma Y U U U U U U U U
Watermelon Citrulline Urine Y U U U U U U U U
aQuestions related to each of the validation criteria: Q1. Is the marker compound plausible as a specific BFI for the food or food group (chemical/biological
plausibility)?, Q2. Is there a dose-response relationship at relevant intake levels of the targeted food (quantitative aspect)?, Q3. Is the biomarkers kinetics described
adequately to make a wise choice of sample type, frequency and time window (time-response) [a single-meal time-response relationship, b: repeated intakes
have]?, Q4. Has the marker been shown to be robust after intake of complex meals reflecting dietary habits of the targeted population (robustness)?, Q5. Has the
marker been shown to compare well with other markers or questionnaire data for the same food/food group (reliability)?, Q6. Is the marker chemically and
biologically stable during bio specimen collection and storage, making measurements reliable and feasible (stability)?, Q7. Are analytical variability (CV %),
accuracy, sensitivity, and specificity known as adequate for at least one reported analytical method (analytical performance)?, Q8. Has the analysis been
successfully reproduced in another laboratory (reproducibility)?
Y yes the criterion is fulfilled, Y* the criterion is partially fulfilled but requires further investigation, N no the principle has not been fulfilled after investigation, U
unknown; further data is required to determine the validation of the criterion, 6-OH-MTβC sulfate 6-hydroxy-1-methyl-1,2,3,4-tetrahydro-β-carboline sulfate
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serum samples was included. Herein, dopamine,
dopamine-3-O-sulfate, dopamine-4-sulfate, and 3-
methoxytyramine-sulfate were detected in plasma as
highly discriminant metabolites for the banana interven-
tion [42, 44, 47]. Other authors examined plasma dopa-
mine responses using targeted methods. In a small pilot
study, the addition of one banana to a complex meal sig-
nificantly increased dopamine levels in plasma 1 h after
intake from 5.8 ng/mL at baseline to 92.5 ng/mL [43]. A
case report about an anorexic adolescent who consumed
> 20 bananas/day for 26 months mentioned a 20-fold in-
crease over the normal range of plasma dopamine,
which corrected towards normality when the patient re-
sumed the restrictive food ingestion [46]. The latter
shows that the intake of banana can increase plasma
dopamine to extremely high levels over an extended
period of time.
Furthermore, the study by Wang et al. revealed
dopamine-3-O-sulfate (r = 0.33, P < 0.0001; AUC =
0.76), dopamine-4-sulfate (r = 0.34, P < 0.0001; AUC =
0.74), and 3-methoxytyramine sulfate (r = 0.22, P <
0.0001; AUC = 0.70) as serum metabolites significantly
correlated to banana intake with a good ability to distin-
guish high and low consumers of banana [48]. These ob-
servations support the interest of these three metabolites
as candidate BFIs for banana intake in plasma as well as
in urine. Their level of validation is discussed below and
summarized in Table 2.
In urine samples from a randomized controlled, cross-
over meal study, dopamine sulfate was observed as a
highly discriminant metabolite (VIP > 2; R2 = 0.89, Q2 =
0.732) for banana consumption, and seven-fold higher
intensity (P < 0.001) after the intake of the fruit than
control [49]. Additionally, it was observed in higher in-
tensity in the urine of high consumers of banana com-
pared to non-consumers (3-fold higher; P = 6.7 × 10−3)
in a cross-sectional study on a German population, thus
supporting its robustness [49]. Dopamine sulfate was a
key component of the combinations of metabolites
which performed best to predict banana intake, while its
performance as a unique biomarker was lower [49].
Regarding the validation criteria, no clear information
is available on the dose-response after banana intake for
dopamine metabolites in plasma or urine. The time-
response in plasma showed an elevation 1–2 h after the
intake of banana, persisting up to 8 h after consumption
[43, 70] (Table 2). Urinary excretion of dopamine metab-
olites peaked 2–4 h after the intake and continued up to
12 h [70]. As for the chemical aspects of the validation,
mild acidification of urine samples may be used to avoid
catecholamine-oxidation and deconjugation [71]. Sample
storage at − 80 °C should be preferred for catecholamine
preservation [72]. Liquid chromatographic methods with
different detectors, including mass spectrometry,
fluorometric, and electrochemical detection, exist for the
determination of dopamine, 3-methoxytyramine and its
conjugates in plasma and urine [67, 73, 74]. However,
conjugated standards of dopamine or 3-methoxytyramine
and other compounds are not commercially available for
quantification, which may complicate their use as BFIs.
Another metabolite associated with banana intake is sal-
solinol. This compound is synthesized in banana by the
condensation of dopamine and acetaldehyde (Pictet-
Spengler reaction) [75]. It is also an endogenous metabol-
ite [76]. Salsolinol concentration in banana pulp is of 6.3 ×
10−2 μg/g and it is present at lower concentration in other
sources including beer (0.5 × 10−2 to 1.3 × 10−2 μg/g) and
French wine (3.3 × 10−3 to 4.9 × 10−3 μg/g ) [77–79]. Sal-
solinol is also highly present in cocoa powder (25 μg/g)
and chocolate (19 μg/g) [80]. There are two existing iso-
mers of salsolinol, the (R) isomer that is proposed to be
mainly of endogenous origin and the (S) enantiomer that
may be more susceptible to diet. Strolin-Benedetti et al.
reported that in 24 h urine samples of 6 subjects before
consumption of banana, the concentration of (S)-salsolinol
was close to zero and increased after the intake of dried
banana. In contrast, the (R) isomer increased after the in-
take of the fruit but was already present prior consump-
tion [45]. Lee et al. studied the influence of banana intake
on blood concentration of salsolinol in healthy subjects.
They showed that after the intake of one banana fruit, the
concentration of salsolinol increased from 0.16 ± 0.12 to
5.8 ± 7.6 ng/mL and from 0.23 ± 0.16 to 6.6 ± 8.7 ng/mL,
for the (S)- and (R)-forms, respectively, 1.5 h post-
consumption [43]. This shows that the consumption of
banana causes a detectable increase of salsolinol in
plasma. The kinetics of this compound was studied only
in rats, after gavage with 10 μg of salsolinol and 3 g of ba-
nana. In both interventions, salsolinol increased in plasma
1 h after intake and cleared 14 h post consumption [43].
Salsolinol sulfate was observed as the most distinctive
urinary metabolite with a 46-fold higher intensity after a
single dose of banana compared to a control meal in 12
healthy subjects (VIP > 2; R2 = 0.89, Q2 = 0.732; P <
0.001) [49]. In the KarMeN cross-sectional study, this
metabolite was also detected in higher intensity in the
urine samples of high-consumers compared to non-
consumers (10-fold higher in high consumers, P = 2 ×
10−2). However, further analysis showed that salsolinol
sulfate alone was not specific enough to predict con-
sumers and non-consumers of banana in this population
(misclassification rate > 30%). The robustness of plasma
and urine salsolinol as a biomarker of banana intake is
possibly challenged by the intake of chocolate, and/or al-
cohol as their consumption was shown to markedly ele-
vate the levels of salsolinol in biofluids [81]. Intervention
studies comparing the response of salsolinol or its conju-
gates to the intake of different salsolinol-containing
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foods are needed to further clarify the potential use of
salsolinol as a candidate BFI for banana, possibly as a
component of a multi-marker.
Among the assessed studies, the one by Vázquez-Man-
jarrez et al. was specially designed for the discovery and
validation of banana biomarkers. Herein, urine samples
from two different study designs were analyzed, a con-
trolled, cross-over meal study with 240 g of banana (n =
12) and a cross-sectional study (KarMeN) (n = 78) with
high (126–378 g of banana), low (47.3–94.5 g of banana),
and non-consumers of banana using an untargeted
multi-platform metabolomics approach [49]. Thirty-
three banana-derived metabolites were identified in
urine in the meal study, including HIAA, dopamine, and
salsolinol metabolites, which have been discussed above,
and other highly distinctive metabolites such as methox-
yeugenol glucuronide (VIP > 2, R2 = 0.89, Q2 = 0.732;
26-fold higher in banana than control, P = 1.3 × 10−10),
2-isopropylmalic acid (VIP > 2, R2 = 0.89, Q2 = 0.732; 9-
fold higher in banana than control P = 1.4 × 10−7), N-
acetyldopamine sulfate (VIP > 2, R2 = 0.89, Q2 = 0.732;
4-fold higher in banana than control P = 1.1 × 10−6), 6-
hydroxy-1-methyl-1,2,3,4-tetrahydro-β-carboline sulfate
(6-OH-MTβC sulfate) (VIP > 2, R2 = 0.89, Q2 = 0.732;
4-fold higher in banana than control, P = 2.3 × 10−2).
The cross-sectional KarMeN study showed that methox-
yeugenol glucuronide (P = 4.70 × 10−5), dopamine sul-
fate (P = 6.7 × 10−3), salsolinol sulfate (P = 2 × 10−2), 6-
OH-MTβC sulfate (P = 3.6 × 10−2), and xanthurenic
acid (P = 6.7 × 10−3) had significant higher intensities,
ranging from 6- to 25-fold change, in the urine of high-
consumers of banana compared to non-consumers,
while only methoxyeugenol glucuronide was significantly
higher (15-fold, P = 5.20 × 10−5) in low-consumers com-
pared to non-consumers [49]. None of the putative bio-
markers was robust enough when used alone, but the
authors demonstrated that dopamine sulfate and meth-
oxyeugenol glucuronide was the best parsimonious com-
bination to detect the intake of banana in high
consumers (AUC = 0.92, ER = 0.11) and low consumers
(AUC = 0.87, ER = 0.19) [49]. The origin of methoxyeu-
genol glucuronide was attributed to the metabolism of
the characteristic banana aroma methoxyeugenol and
elemicin [82]. Methoxyeugenol and elemicin were also
reported in nutmeg and star anise [82, 83], respectively,
which represent marginal confounders. Regarding dose-
response, the intensity of the combined BFIs showed a
linear trend with the amount of banana consumed in the
intervention study and that reported in 24 h recalls by
the high and low consumers in the cross-sectional study.
However, quantitative studies are required to fully valid-
ate the proposed combined BFI in this critical aspect
(Table 2). The metabolite 6-OH-MTβC sulfate was also
frequently present in the best combinations of
biomarkers reflecting high banana intake in the KarMeN
study. The 6-OH-MTβC derives from the condensation
of serotonin with acetaldehyde and is present in banana
in higher concentrations (1.87 mg/kg) than in other
fruits, including tomato (0.71 mg/kg), kiwi (0.31 mg/kg),
and pineapple (0.62 mg/kg) [84]. Dark chocolate con-
tains higher levels of 6-OH-MTβC (2.64 mg/kg) [85]
than banana and thus would constitute a potential
confounder.
Melatonin metabolites have been associated with ba-
nana consumption in other selected publications. While
melatonin is produced endogenously in the pineal gland,
the intake of melatonin-rich foods such as banana, pine-
apple, cherries, and orange substantially elevate the con-
centration of melatonin and 6-sulfatoxymelatonin, its
main metabolite, in urine and serum [86, 87]. Other
dietary sources of melatonin are walnuts, mango, papaya,
grapes, wine, and olive oil. The use of melatonin and its
main metabolite as a candidate BFI for banana or any
other fruit is also hindered by its fluctuation during the
daytime [88] and by the fact that melatonin is sold over-
the-counter in different countries as a supplement to ad-
just sleeping disorders.
Many other metabolites have been identified in biofluids
after the intake of banana but have less relevance as candi-
date BFIs (Table S2). 3,4-Dihydroxyphenyl-acetic acid,
homovanillic acid, 3-hydroxytyrosol, and 5,6-dihydroxyin-
dole were observed as part of the “dopamine signature” of
banana [36, 38, 49]. However, 3,4-dihydroxyphenyl acetic
acid and homovanillic acid originate from the microbial
metabolism of polyphenols, which are widely distributed
in plant-based foods [89, 90]. 3-Hydroxytyrosol in urine
may better reflect olive-oil consumption [59]. Plasma 2,3-
dihydroxy-isovalerate, 4-guanidinobutanoate, ferulic acid
4-sulfate, and 4-acetylphenol sulfate were associated with
banana intake in controlled intervention studies with ba-
nana [42, 47]. However, 2,3-dihydroxy-isovalerate is an
intermediate in the biosynthesis of valine, leucine, and iso-
leucine while 4-guanidinobutanoate participates in the
metabolic pathway of arginine. Ferulic-acid-4 sulfate is a
metabolite of ferulic acid and caffeic acid, which are
widely distributed in fruits, cereals, and coffee [28, 30]. 4-
Acetylphenol has been detected in different medicinal
herbs and is a flavoring and aroma ingredient in roasted
coffee, beer, mango, and cranberry [21]. Interestingly 2-
isopropylmalic acid, eugenol sulfate, and fructose were ob-
served by different groups after banana intake [42, 47, 49].
Fructose is a common carbohydrate present in a wide
range of foods, which excludes its use as a BFI of banana.
2-Isopropylmalic acid has been identified as a key com-
pound for organoleptic characteristics of melon [91] and
is present in other vegetables and fruits including lettuce
and tomato juice [92, 93]. The fact that this metabolite
was recovered in biofluids following consumption of
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different vegetal sources including pear, banana, and peas
[42, 47, 49, 94] suggests its possible utility as putative BFI
for the general intake of this food group. Eugenol sulfate
results from the phase II metabolism of the aroma com-
pound eugenol which is present in banana and other
highly consumed fruits such as apple, apricot, and cherry
as well as spices including black pepper and clove [21].
The microbiota metabolites of tryptophan, indolepropio-
nate, and indoleacetate have been associated with the in-
take of banana [47, 95] but also with the consumption of
other fruits including apple and pear [95]. Xanthurenic
acid, which was found to be increased in urine after ba-
nana intake [49], originates from the kynurenine pathway
of tryptophan degradation [96]. Whereas banana has a
higher content (10mg/100 g) of tryptophan than other
fruits (e.g., apple 3mg/100 g) [97], other dietary sources
very rich in tryptophan, e.g., cheese and fermented prod-
ucts would act as strong confounders [98].
Late urinary excretion of al N-methyl-2-pyridione-5-
carboxylic acid, likely a microbial metabolite of trigonel-
line, was observed by Vázquez-Manjarrez et al. [49], but
the presence of trigonelline in coffee excludes its use as
BFI for banana. Metabolites from carboxylic acids, sac-
charides, and amino acids were also reported in the
urine. Among them, sinapic acid-sulfate, hydrocinnamic
acid sulfate, vanillic acid, mevalonic acid, azelaic acid, 1,
5 anhydrosorbitol, fructose, glyceraldehyde, and 2-ethyl-
3-hydroxyl propionic acid were found to be increased in
urine samples in studies within a controlled setting but
not under free-living conditions [49].
In conclusion, we have identified several candidate
BFIs for banana intake including metabolites of catechol-
amines, indolamines, and specific aroma compounds
(Fig. 2). While these metabolites are candidate BFIs for
banana, they are challenged when considered individu-
ally by their endogenous presence in the human body or
in other foods. However, the combined use of several
candidate BFIs, namely dopamine sulfate, salsolinol sul-
fate, 6-OH-MTβC sulfate, and methoxyeugenol glucuro-
nide in urine and HIAA along with 3-methoxytyramine
sulfate in plasma, offers a more robust alternative to de-
termine exposure to banana in free-living conditions.
These candidate biomarkers can reflect banana intake
qualitatively (absence/presence of consumption) but
dose-response studies must be conducted to push them
forward as quantitative BFIs.
Papaya and watermelon biomarkers
Much less information has been found on candidate
BFIs for tropical fruits other than banana. Some caroten-
oids have been proposed as biomarkers of tropical fruit
intake. In particular, lycopene, β-carotene and β-
cryptoxanthin have been associated with papaya and
watermelon intake, while lutein and β-carotene have
been associated with intake of papaya and mango [99–
101]. Tropical fruits have been studied as sources of
pro-vitamin A carotenoids for many developing coun-
tries with a high occurrence of vitamin A deficiency, and
the literature reflects this interest. Carotenes are present
in too many foods to be envisaged as biomarkers for
specific tropical fruits. β-Cryptoxanthin was shown to
increase in plasma after acute intake of papaya [102] and
has also been correlated with habitual intake of tropical
fruits in a study with 159 Costa-Rican adolescents [101].
Papaya was the best food predictor of plasma β-
cryptoxanthin in this study. Yet, although papaya is in-
deed one of the richest sources of β-cryptoxanthin, this
compound can also originate from other orange- or red-
colored foods such as orange, mango, apricot, sweet pep-
pers, and pumpkin, as well as from spices and herbs in-
cluding paprika, dill, and basil [30, 103]. In the Nurse’s
Health study conducted in a US population with low
consumption of papaya, orange juice was actually re-
ported to be the major determinant of plasma β-
cryptoxanthin [104].
Watermelon, and to a lesser extent papaya, contains a
substantial amount of lycopene in a highly bioavailable
form [102]. Watermelon has a lycopene content ranging
from 4.8 to 13.5mg/100 g fresh weight representing a con-
tent equivalent to that measured in most tomato cultivars
[103]. However, processed forms of tomato such as to-
mato sauce are even more concentrated. Considering the
higher consumption of tomato products compared to
watermelon in most populations, blood concentration of
lycopene is more likely to reflect the intake of tomato and
derived products than that of watermelon.
Although the common dietary carotenoids lack specifi-
city for tropical fruit intake, it cannot be ruled out that
less studied carotenoids among the dozens identified in
tropical fruits, for example, cryptoxanthin-5,8-epoxide or
sapotexanthin may arise as more specific candidate bio-
markers in future metabolomic studies [105].
Aside from carotenoids, the literature search revealed
citrulline as a possible biomarker of watermelon intake.
Interestingly, the name of this amino acid was derived
from the latin name of watermelon, Citrullus vulgaris,
from which it was first isolated. A case study reported a
ten times elevation of citrulline plasma concentration in
a young girl who was consuming large quantities of
watermelon, and this was confirmed in a dietary inter-
vention on six healthy adult volunteers [50]. Plasma cit-
rulline peaked 1 h after watermelon intake (593 μM),
was still elevated at 8 h and returned to the normal
range (20–40 μM) at 24 h. Other authors have observed
L-citrulline responses in plasma following watermelon
intake. A 16-day supplementation with 300 mL/day of a
watermelon concentrated juice providing 3.4 g of citrul-
line/day resulted in 3.5–4.6 fold higher plasma
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concentrations of citrulline compared to control or apple
juice interventions [51]. A transitory increase in plasma
L-citrulline occurred for 20 subjects who consumed 0.2
g/kg of watermelon puree every 15 min during a physical
challenge, with a return to baseline levels 3–5 h after the
end of the supplementation [52]. Collins et al. did not
observe any significant change in L-citrulline plasma
concentration following the ingestion of watermelon
juice, up to 6 cups/day for 3 weeks [53]. However, mea-
surements were made on 12 h fasting plasma samples,
which concurs with the short-term responses observed
by other authors. Citrulline also has an endogenous ori-
gin, synthetized from glutamine or arginine in the enter-
ocytes [106]. It is a key intermediate of the urea cycle in
the liver and is readily converted to arginine and then
nitric oxide in the kidney and vascular endothelium. Cit-
rulline plasma concentration reflects the equilibrium be-
tween its synthesis in the intestine and its conversion to
arginine in the kidney. Low or high citrulline status has
been proposed as a biomarker of intestinal dysfunction
in various intestinal pathologies as well as markers of
acute kidney failure and of some inborn errors of the
urea cycle [106]. It is worth noting that after watermelon
intake plasma arginine was also modestly elevated,
whereas venous ammonia, plasma glutamine, and other
amino acids remained in the normal range, which does
not correspond to the metabolic patterns classically ob-
served with urea cycle, renal or intestinal disorders.
In conclusion, the concentration of citrulline in plasma
and possibly in urine could be further explored as candi-
date biomarker for assessing watermelon intake in healthy
individuals (Fig. 2). Regarding papaya, there are no puta-
tive BFIs reported in the literature yet. To further discover
candidate BFIs for both fruits, controlled intervention tri-
als with different doses of the fruits and applying an untar-
geted metabolomics approach may be performed.
Avocado biomarkers
Avocado (Persea Americana) is unique in its low content
in starch and sugars and high content in monounsaturated
fatty acids 71% [107]. Using a semi-targeted GCxGC-MS
sugar profiling method, Mack et al. analyzed 24 h urine
samples of 301 volunteers of the KarMeN cross-sectional
study to search associations between excreted sugar me-
tabolites and the dietary information obtained with 24-
dietary recalls [54]. From the Spearman rank correlation
analyses with the entire population, two seven-carbon car-
bohydrates, perseitol (ρ = 0.33, p values < 0.0001) and
mannoheptulose (ρ = 0.2702, p values < 0.0001) were sig-
nificantly associated with avocado intake. Further correl-
ation analyses including only avocado consumers (n = 9)
and non-consumers (n = 18) confirmed the strong associ-
ation of perseitol ρ = 0.871 and mannoheptulose ρ = 0.778
with avocado consumption [54].
The authors analyzed perseitol and mannoheptulose in
75 foodstuffs to determine their plausibility and specifi-
city as candidate BFIs for avocado. Perseitol was only
observed in avocado while mannoheptulose was more
concentrated in avocado than in the other fruits and
vegetables where it was detected (carrot, blueberry, fig,
and tomato) [54].
Wamelink et al. have developed a HPLC-QqQ-MS/MS
method of analysis for the seven-carbon carbohydrates
and validated it with a small human intervention on 3
subjects consuming avocado (75–200 g) [55]. Urine ex-
cretion of perseitol and mannoheptulose but not of
other seven-carbon carbohydrates were elevated between
3 and 12 h after avocado intake. A high interindividual
variation was observed that may be due to a different
content of C7 carbohydrates in avocados. Of note, in
subjects with transaldolase deficiency, a recently discov-
ered pentose phosphate pathway alteration, a subtle ele-
vation of mannoheptulose and perseitol in urine can be
observed along with other C7 carbohydrates and polyols
[55]. This will deserve further attention to determine
whether intrinsic factors can affect the excretion of the
candidate biomarkers and jeopardize their use.
In conclusion, the limited data available suggest that
perseitol and mannoheptulose may be considered as
short-term candidate BFIs for avocado. They have been
validated for plausibility, and partially for robustness and
time-response (Table 2, Fig. 2). However, human studies
with larger sample sizes are needed to further validate
these candidate BFIs and assess dose-response, reliabil-
ity, and performance of their quantification method(s).
Date biomarkers
Date fruit is a highly nutritious fruit that contains about
70% of carbohydrates, as well as dietary fibers and a wide
range of micronutrients and secondary metabolites [108,
109]. The first and only study that aimed to identify meta-
bolic changes occurring in blood after consumption of
date fruit was conducted by Mathew et al. [110]. They ap-
plied an untargeted metabolomics approach based on LC-
MS on blood samples from 21 subjects who underwent
three dietary interventions: (1) a control glucose drink, (2)
ten date fruits of the Deglet Nour variety, and (3) ten date
fruits of the Khlas variety. A total of 28 molecules were
found to significantly increase (Bonferroni corrected p
value < 0.05) over 2 h after the date fruit challenges,
among which 20 were identified. Several phenolic acid
metabolites were found to be discriminant, including feru-
lic acid 4-sulfate, caffeic acid-sulfate, 4-vinylguaiacol sul-
fate, and vanillic alcohol sulfate. This was consistent with
the presence of 3,4,5-trimethoxycinnamate, 3,4-dimethox-
ycinammic acid, 4-hydroxycinnamate, dihydroferulic acid,
ferulic acid, and isoferulic acid in the date fruit. However,
those phenolic metabolites can derive from many fruits
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and vegetables and are therefore of little interest as candi-
date biomarkers for date fruit. In the same study, 2-
isopropylmalic acid was observed as a distinctive metabol-
ite for recent date intake. As already mentioned, this com-
pound is also recovered in biofluids after intake of peas or
different fruits including banana, tomato, and pear [42, 49,
93, 94]. Some carboxyethylated amino acids were detected
in plasma after the intake of both varieties of dates, includ-
ing 1-carboxyethylisoleucine, 1-carboxyethylleucine, 1-
carboxyethyltyrosine, and 1-carboxyethylvaline. These
compounds, considered to be advanced glycation prod-
ucts, are formed by non-enzymatic reactions between re-
ducing sugars and proteins [111, 112]. They are most
likely formed in the dates during drying, but they might
also be formed endogenously after intake of dates as a
consequence of their high content of fructose [112].
Based the scarce information available on human me-
tabolites observed after intake of date fruit, it is not yet
possible to identify a candidate BFI. Some more specific
caffeoylshikimic acids, e.g., dactylifric acid (3-O-caffeoyl-
shikimic acid), neodactylifric acid (5-O-caffeoylshikimic
acid), and isodactylifric acid (4- O-caffeoylshikimic acid)
resulting from enzymatic browning of date fruit [29,
113] and xanthoxylin [114] may be of interest as putative
biomarkers but their metabolic fate in humans remain
to be elucidated.
Pomegranate biomarkers
Pomegranate is mainly consumed fresh or in the form of
juice. It is characterized by its content of rare ellagitan-
nins, including punicalin and punicalagin A and B. Thus,
it comes as no surprise that most of the retrieved litera-
ture focused on urolithins. Urolithins are dibenzo-[b,d]
pyran-6-one derivatives produced from ellagic acid and
ellagitannins by the gut microbiota [115, 116] and to
which various beneficial effects on human health have
been attributed [117, 118].
After consumption of pomegranate, urolithins appear
in plasma 6–8 h after exposure and persist in plasma
and urine up to 48–72 h [116, 119–125] (Table S2). It is
likely that the primary precursor of urolithins from pom-
egranate is punicalagin, which constitutes the major ella-
gitannin present in this fruit.
Two main factors limit the usefulness of urolithins as
BFIs for pomegranate. Firstly, their precursors, namely
ellagitannins and ellagic acid, are distributed in other
highly consumed foods, including berries and walnuts.
The estimated dietary contribution of total ellagitannins
as assessed by 3-day dietary records and chromato-
graphic analysis revealed five primary dietary sources of
ellagitannins: strawberries, blackberries, walnuts, pom-
egranate juice, and preserved foods [123]. Of these
foods, berries accounted for almost half (42%) of the es-
timated intake of ellagitannins, followed by pomegranate
(27.6%), walnuts (26.7%), and strawberry jam (4.1%). Tea
infusions (Camelia Sinensis) also contain ellagitannins
and ellagic acid [126]. The high frequency of consump-
tion of tea, berries, and walnuts makes them potential
confounders for the use of urolithins as BFIs for pom-
egranate. The second limiting factor is the high inter-
individual variation in the production of urolithins
caused by variable gut microbiota functionality [127].
From the analysis of urine samples of subjects involved
in different dietary interventions with walnuts, pom-
egranate, or berries, the group of Tomás-Barberan and
others reported the occurrence of three ellagitannin-
metabolizing phenotypes: metabotype A, metabotype B,
and metabotype 0 [115–117, 124, 127–131]. Metabotype
A subjects, representing 25–80% of the tested popula-
tions, produce solely urolithin A conjugates. Metabotype
B found in 10–50% of the volunteers produce isouro-
lithin A and urolithin B besides urolithin A. Lastly, sub-
jects with metabotype 0, less than 10% of the population,
do not produce any of these urolithins.
In conclusion, urolithins are not promising candidate
BFIs for pomegranate and additional work has to be
done to identify specific BFIs that would apply for all
subjects regardless of their metabotype. As no other spe-
cific pomegranate component has been highlighted so
far, the best approach to identify putative BFIs for pom-
egranate is to conduct an explorative intervention study
with untargeted metabolomic profiling of the collected
biofluids and later validate the robustness of the discov-
ered candidates in a population in free-living conditions.
Mango biomarkers
Mango is a rich source of phytochemicals including di-
verse polyphenols such as catechins, quercetin, kaemp-
ferol, rhamnetin, anthocyanins, gallic acid, ellagic acid,
protocatechuic acid, and benzoic acid, which are all
widely distributed in other fruits [132, 133]. Gallic acid
has been found as the most abundant in mango pulp
[134] along with different polymers of the same metab-
olite in the form of gallotannins. Barnes et al. studied
the bioavailability of galloyl derivatives after consump-
tion of mango (Keitt variety). Eleven healthy volunteers
underwent a dietary intervention with 400 g of mango
daily for 10 days. Plasma and urine samples were col-
lected on the first and last days of intervention. While
no response was observed in plasma, seven metabolites
of gallic acid and pyrogallol derivatives were detected in
urine [134]. The gallic acid metabolites 4-methylgallic
acid and 4-O-methylgallic acid-3-O-sulfate accounted
for 43–54% of the total administered gallic acid and
showed a rapid urinary excretion peaking at 6 h and
returning to baseline 8–12 h after the intake of mango
[134]. The other five metabolites were pyrogallol conju-
gates that originate from the microbial decarboxylation
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of gallic acid, namely isoforms of O-methylpyrogallol-O-
sulfate, pyrogallol-O-sulfate, and deoxypyrogallol-O-sul-
fate [135]. These five metabolites had a urinary excretion
peaking at 12 h after the consumption of mango. After
10 days with 400 g/day of mango, pyrogallol-O-sulfate
and deoxypyrogallol-O-sulfate were the most prevalent
metabolites with a significantly increased urinary excre-
tion (> 60%, P < 0.05).
Quirós-Sauceda et al. reported consistent results on
pyrogallol metabolites in hydrolyzed plasma and urine
samples of 12 male volunteers after the intake of a differ-
ent variety of mango (Ataulfo) [133]. Five compounds, i.e.,
gallic acid, chlorogenic acid, protocatechuic acid, ferulic
acid, and genistic acid, all unspecific for mango intake,
were detected in hydrolyzed plasma 2–4 h after the intake
of either 500 g of mango pulp or 721 g of mango juice. In
urine, gallic acid, pyrogallol, chlorogenic acid, vanillic acid,
p-coumaric acid, ferulic acid, and sinapic acid were de-
tected [133]. Most metabolites showed a rapid urinary ex-
cretion while pyrogallol was observed over 8–24 h after
the intake of mango in both forms.
None of the aforementioned phenolic metabolites may
be considered as candidate BFIs for mango due their low
specificity for this fruit. Pyrogallol and its conjugates
have been detected in human biofluids following the in-
take of other fruit products, such as grape juice and ber-
ries [136, 137]. Mangiferin, a xanthonoid, has been
isolated from the pulp of different mango varieties in-
cluding the Keitt and Ataulfo used in the studies dis-
cussed in this section [132]. While its presence and
specificity for mango makes it plausible candidate BFI
for mango, no information is available yet on the bio-
availability of this compound. Its combination with me-
tabolites of pyrogallol may be further tested as a
candidate multi-marker for mango.
Potential biomarkers for other tropical fruits
In spite of the frequent consumption of kiwi, musk-
melon, pineapple, guava, and persimmon, there is a re-
markable paucity of information on their metabolites in
human studies, and even fewer data are available for the
less common tropical fruits acerola, litchi, pitaya (dragon
fruit), and coconut.
Abdul et al. examined the metabolic profiling of three
varieties of kiwi including the most consumed Hayward
cultivar (Actinidia deliciosa), the mini kiwi (Actindia
arguta), and the less known Bidan (Actinidia eriantha)
[138]. Only non-specific compounds were detected, in-
cluding phenylalanine, tyrosine, arginine, citric acid,
glutamine-hydroxy-L-proline, 4-aminobutyrate (GABA),
glutamate, glutamine, quinic acid, actinic acid, shikimate,
mannose, syringic acid, and afzelechin [22, 138].
Muskmelon, or cantaloupe, is a widely consumed fruit
in different countries. Besides their content in β-
cryptoxanthins, other interesting phytochemicals re-
ported in this fruit are cucurbitin and cucurbitacin E
and B [21, 22, 139] (Figure S1). Little is known about the
bioavailability of these compounds after consumption of
muskmelon, and they have also been reported in other
fruits of the cucurbitacae family, such as cucumber or
pumpkin [22, 24]
Regarding guava, while no publications were retrieved
that report specific metabolites following its intake,
some specific terpenes have been described in the fruit.
Qin et al. reported the presence of guadial, guajadial, 4,
5-diepipsidial, psiguadial, and two novel meroterpenoids,
psiguajavadial A and B [140]. Although studies on the
bioavailability and pharmacokinetics of terpenes in
humans are scarce, evidence indicating their bioavailabil-
ity after the intake of other fruits exists [141, 142]. Thus,
these metabolites might constitute putative biomarkers
for the intake of guava (Figure S1). Moreover, the pres-
ence of mongolicain-A, an ellagitannin, has been re-
ported solely in guava [22, 29] advocating for a potential
role as a putative BFI for this fruit. However, as dis-
cussed previously its bioavailability in humans in not
documented and it may be metabolized into non-
specific compounds like urolithins with a high interindi-
vidual variation.
Pineapple belongs to the Ananas cosmosus species.
Like in other tropical fruits, melatonin is present in
pineapple and its consumption has been shown to pro-
duce an elevation of 6-sulfatoxymelatonin in urine of
healthy adults [143]. However, as discussed in the “Ba-
nana biomarkers” section this metabolite is not relevant
as a BFI for either pineapple or any other fruit due to its
natural abundance in many fruits and in supplements.
Ananasic acid, a specific triterpenoid reported in pine-
apple [21, 22, 144], may be further studied for its plausi-
bility as a putative BFI for pineapple.
Leucodelphinidin-3-glucoside [145], kakidiol, and
methyl-phaeophorbide A and B are listed in different
food databases for persimmon [21–23] (Figure S1). In-
formation on the bioavailability of these compounds
after human consumption of persimmon is not available.
Finally, no specific phytochemicals were identified for li-
tchi, pitaya (dragon fruit), coconut, or acerola in our re-
view process.
Conclusion
In spite of the important presence of tropical fruits in the
human diet, there has been very little interest so far for
biomarkers of their intake, and except for banana, no
studies have been specifically designed for identifying such
biomarkers. For banana consumption, dopamine sulfate,
salsolinol sulfate, 6-OH-MTβC sulfate, methoxyeugenol-
glucuronide, HIAA, and 3-methoxytyramine sulfate are
candidate biomarkers. The combination of some of these
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individual compounds may strengthen their robustness to
overcome the exposure to potential confounders, as dem-
onstrated for the combination of methoxyeugenol glucu-
ronide and dopamine sulfate in the urine. However, dose-
response studies are needed to validate the latter combin-
ation as an accurate quantitative BFI for banana. Citrulline
is a candidate BFI for watermelon but its robustness, espe-
cially given its endogenous formation in the gut epithe-
lium, has to be assessed in population studies. Perseitol
and mannoheptulose are promising candidate BFIs for
avocado but again, larger population studies are required
to document their robustness and reliability. A few human
intervention studies with mango, papaya, pomegranate,
and dates have been performed, but no candidate BFIs
were identified so far for these fruits. Specific phytochemi-
cals have been described in some tropical fruits including
mango, pineapple, guava, and persimmon, but there is vir-
tually no information regarding their bioavailability and
interest as putative BFIs.
The way forward for discovering BFIs for tropical
fruits is certainly the application of untargeted metabo-
lomics, where no a priori hypothesis of candidate bio-
markers is required. Complementary studies with
different study design, such as controlled cross-over tri-
als with different doses of the fruits, and cross-sectional
studies with comprehensive dietary information will
have to be used to document the criteria of the valid-
ation scheme for BFIs.
In parallel, data collection and sharing in online re-
sources on the phytochemical composition of tropical
fruits and the bioavailability of these phytochemicals
should facilitate the identification of specific phytochem-
ical metabolites in metabolomic profiles that may consti-
tute new candidate BFIs.
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